Streetbeat News

Stock Prices

AUID

AUUD

AVGO

CIFR

CYN

INSG

NVNI

PRST

RTC

SLNH

SOBR

SVRE

The article highlights the intraday movements of 12 information technology stocks on Thursday. Notable gainers include Auddia, AuthID, Broadcom, Inseego, Soluna Holdings, and Cipher Mining. Significant losers include Baijiayun Group, Saverone 2014, Cyngn, Presto Automation, Sobr Safe, and Nvni Group.

Portfolio Pulse from Benzinga Insights

June 13, 2024 | 4:31 pm

KFY

Korn Ferry shares are trading higher after the company reported Q4 EPS and sales above estimates.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:30 pm

STX

Seagate Tech Hldgs (NYSE:STX) has seen a 4.43% increase in its short percent of float, now at 6.6% of all regular shares available for trading. This is higher than the peer group average of 5.98%. It would take traders 4.76 days to cover their short positions on average.

Portfolio Pulse from Benzinga Insights

June 13, 2024 | 4:30 pm

IPW

iPower shares are trading higher after the company announced it was approved as a Temu U.S. Seller.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:27 pm

TLT

Goldman Sachs reaffirms its forecast for two interest rate cuts in 2024, starting in September, despite the Federal Reserve's hawkish surprise in its June meeting. The Fed acknowledged modest progress on inflation, which has dropped significantly. Market participants now see a high probability of rate cuts, pushing bond yields down and equity indices up. The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) has risen over 2% for the week.

Portfolio Pulse from Piero Cingari

June 13, 2024 | 4:26 pm

CRDL

Cardiol Therapeutics shares are trading lower following the announcement of 8-week clinical data from its Phase II MAvERIC-Pilot study on CardiolRx for symptomatic recurrent pericarditis.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:24 pm

RGEN

Repligen shares are trading lower following the announcement of a CEO transition.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:22 pm

CARA

Cara Therapeutics (NASDAQ:CARA) shares dropped significantly after analysts from Needham and HC Wainwright downgraded the stock due to the failure of a key clinical trial and the lack of future value drivers. The company plans to halt its NP program and explore strategic alternatives.

Portfolio Pulse from Priya Nigam

June 13, 2024 | 4:21 pm

SBFM

Sunshine Biopharma shares are trading higher following a purchase disclosure by Texas Congressman Roger Williams.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:16 pm

CERO

CERo Therapeutics shares are trading lower following the company's execution of pre-IND manufacturing activities for its lead therapeutic, CER-1236.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 4:09 pm